Medplus Health Services Share Price Target For Tomorrow, Next Week & Next Month
MedPlus Health Services Limited | |||
 | Price: ₹890.05 (-1.6%) | ||
| 52 Week Low: ₹616.00 52 Week High: ₹1,045.30 | |||
| Market Capital: 8,412.54 Crore (Midcap) | |||
| Healthcare -> Pharmaceutical Retailers | |||
Medplus Health Services Stock Comparison: Medplus Health Services vs Sastasundar Ventures | Medplus Health Services vs Wockhardt | Medplus Health Services vs FDC | Medplus Health Services vs Strides Pharma Science | Medplus Health Services vs Procter & Gamble Health | Medplus Health Services vs Vijaya Diagnostic Centre | |||
Show Table of Contents
Medplus Health Services Recent Performance
Over the past 406 trading days, the value of Medplus Health Services's stock has gained ₹86.85 (+10.81%). On 07 Nov 2023, one share was worth ₹803.20 and by 01 Jul 2025, the value jumped to ₹890.05. During this period it created a highest high of ₹1045.30 and lowest low of ₹598.60.
Medplus Health Services Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 978 (+9.88%) | Price Action: Jul 2023 High |
| Tomorrow Target 2 | 960.45 (+7.9%) | Price Action: 30 May 2025 Low |
| Tomorrow Target 1 | 950 (+6.73%) | Price Action: 03 Jun 2025 High |
| Current Price | 890.05 | Medplus Health Services's share price as of 01 Jul 2025 |
| Stop Loss 1 | 840.05 (-5.62%) | Price Action: 14 May 2025 High |
| Stop Loss 2 | 830.75 (-6.67%) | Price Action: 15 May 2025 High |
| Stop Loss 3 | 821.2 (-7.74%) | Price Action: 28 Apr 2025 High |
Summary
01 Jul 2025: Medplus Health Services finished the day at ₹890.05, losing ₹-14.45 (-1.60%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -7.74% to 9.88% with:
- Target prices: ₹950 to ₹978
- Support levels: ₹840.05 to ₹821.2
- Recent high: ₹908.00
- Recent low: ₹886.95
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Medplus Health Services Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 920 (+3.36%) | Price Action: 05 Jun 2025 High |
| Next Week Target 2 | 910.1 (+2.25%) | Price Action: 03 Jun 2025 Low |
| Next Week Target 1 | 900.15 (+1.12%) | Fibonacci Extension Level 23.60% |
| Current Price | 890.05 | Medplus Health Services's share price as of 01 Jul 2025 |
| Stop Loss 1 | 887.05 (-0.34%) | Price Action: 01 Jul 2025 Low |
| Stop Loss 2 | 878.15 (-1.34%) | Price Action: 21 May 2025 Low |
| Stop Loss 3 | 868 (-2.48%) | Price Action: 22 May 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.48% to 3.36% with:
- Upper targets: ₹900.15 to ₹920
- Support levels: ₹887.05 to ₹868
Medplus Health Services Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 988.9 (+11.1%) | Price Action: 30 May 2025 High |
| Next Month Target 2 | 976.67 (+9.73%) | Fibonacci Extension Level 23.60% |
| Next Month Target 1 | 960.45 (+7.9%) | Price Action: 30 May 2025 Low |
| Current Price | 890.05 | Medplus Health Services's share price as of 01 Jul 2025 |
| Stop Loss 1 | 870.8 (-2.17%) | Technical Indicator: MA50 |
| Stop Loss 2 | 862 (-3.16%) | Price Action: 18 Jun 2025 Low |
| Stop Loss 3 | 849.8 (-4.53%) | Price Action: Jun 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.52% to 11.11% with:
- Target range: ₹960.45 to ₹988.9
- Support levels: ₹870.8 to ₹849.8
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
